BDNF evokes release of endogenous cannabinoids at layer 2/3 inhibitory synapses in the neocortex.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 2957462)

Published in J Neurophysiol on August 18, 2010

Authors

Fouad Lemtiri-Chlieh1, Eric S Levine

Author Affiliations

1: University of Connecticut Health Center, Department of Neuroscience, MC-3401, 263 Farmington Ave., Farmington, CT 06030, USA.

Articles citing this

Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci (2013) 3.53

Long-term plasticity at inhibitory synapses. Curr Opin Neurobiol (2011) 1.41

Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav (2012) 1.31

The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex. J Neurosci (2012) 1.24

Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther (2014) 0.92

Molecular model of cannabis sensitivity in developing neuronal circuits. Trends Pharmacol Sci (2011) 0.90

Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro. Alcohol Clin Exp Res (2012) 0.89

BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons. J Neurosci (2015) 0.86

Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review. Rheumatol Int (2011) 0.83

Cannabinoid modulation of drug reward and the implications of marijuana legalization. Brain Res (2014) 0.80

BDNF-endocannabinoid interactions at neocortical inhibitory synapses require phospholipase C signaling. J Neurophysiol (2013) 0.79

Control of synaptic function by endocannabinoid-mediated retrograde signaling. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.79

Endogenous cannabinoid signaling at inhibitory interneurons. Curr Opin Neurobiol (2013) 0.78

Fluoxetine Facilitates Fear Extinction Through Amygdala Endocannabinoids. Neuropsychopharmacology (2015) 0.78

Regional effects of endocannabinoid, BDNF and FGF receptor signalling on neuroblast motility and guidance along the rostral migratory stream. Mol Cell Neurosci (2014) 0.76

Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses(,.) eNeuro (2015) 0.75

The role of cannabinoids in adult neurogenesis. Br J Pharmacol (2015) 0.75

Examining FKBP5 mRNA expression in human iPSC-derived neural cells. Psychiatry Res (2016) 0.75

Molecular mechanisms of experience-dependent maturation in cortical GABAergic inhibition. J Neurochem (2017) 0.75

Articles cited by this

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature (2001) 6.12

CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science (2003) 5.22

Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci (1999) 4.65

The yin and yang of neurotrophin action. Nat Rev Neurosci (2005) 4.45

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience (1998) 4.39

Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron (2001) 4.15

BDNF and activity-dependent synaptic modulation. Learn Mem (2003) 4.04

Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron (2001) 3.98

TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron (2008) 2.94

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci (1999) 2.92

From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem (2002) 2.79

Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci (2005) 2.32

Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol (1993) 2.27

Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron (2005) 2.23

Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus. J Neurosci (1997) 2.18

K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem (1992) 2.01

Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature (2004) 1.92

Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. J Neurosci (1998) 1.91

Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci (2004) 1.74

Selective cholinergic modulation of cortical GABAergic cell subtypes. J Neurophysiol (1997) 1.68

BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABA(A) receptor surface expression. Eur J Neurosci (2001) 1.60

TRPC3 channels are necessary for brain-derived neurotrophic factor to activate a nonselective cationic current and to induce dendritic spine formation. J Neurosci (2007) 1.56

TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum. Nat Neurosci (2002) 1.54

Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience (2003) 1.54

K-252 compounds: modulators of neurotrophin signal transduction. J Neurochem (1992) 1.49

Brain-derived neurotrophic factor (BDNF) modulates inhibitory, but not excitatory, transmission in the CA1 region of the hippocampus. J Neurophysiol (1998) 1.47

The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol (1987) 1.33

Random response fluctuations lead to spurious paired-pulse facilitation. J Neurosci (2001) 1.33

Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity. J Neurosci (1999) 1.26

Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. J Comp Neurol (1996) 1.26

The dynamic distribution of TrkB receptors before, during, and after synapse formation between cortical neurons. J Neurosci (2006) 1.25

K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses. Mol Biol Cell (1992) 1.24

Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol (2004) 1.19

Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J Pharmacol Exp Ther (1999) 1.15

Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol (2004) 1.13

Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. J Neurophysiol (2003) 1.12

Localization of brain-derived neurotrophic factor and TrkB receptors to postsynaptic densities of adult rat cerebral cortex. J Neurosci Res (2000) 1.09

BDNF induces calcium elevations associated with IBDNF, a nonselective cationic current mediated by TRPC channels. J Neurophysiol (2007) 1.08

Changing patterns of expression and subcellular localization of TrkB in the developing visual system. J Neurosci (1996) 1.08

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem (2007) 1.07

Roles of endocannabinoids in heterosynaptic long-term depression of excitatory synaptic transmission in visual cortex of young mice. J Neurosci (2008) 1.05

Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. Eur J Neurosci (2004) 1.04

Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity. J Neurosci (2010) 1.04

Brain-derived neurotrophic factor attenuates mouse cerebellar granule cell GABA(A) receptor-mediated responses via postsynaptic mechanisms. J Physiol (2003) 1.03

Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission. J Neurophysiol (2008) 1.01

Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases? Curr Med Chem (2007) 1.00

Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. J Neurophysiol (2002) 0.98

K-252a, a potent protein kinase inhibitor, blocks nerve growth factor-induced neurite outgrowth and changes in the phosphorylation of proteins in PC12h cells. J Cell Biol (1988) 0.97

Localization of trkB mRNA in postnatal brain development. J Neurosci Res (1993) 0.97

Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat Neurosci (2009) 0.97

The action of BDNF on GABA(A) currents changes from potentiating to suppressing during maturation of rat hippocampal CA1 pyramidal neurons. J Physiol (2003) 0.96

Brain-derived neurotrophic factor silences GABA synapses onto hypothalamic neuroendocrine cells through a postsynaptic dynamin-mediated mechanism. J Neurophysiol (2006) 0.94

Neurotrophin receptors in the somatosensory cortex of the mature rat: co-localization of p75, trk, isoforms and c-neu. Brain Res (2000) 0.89

BDNF regulates neuronal sensitivity to endocannabinoids. Neurosci Lett (2009) 0.87

In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to Delta-tetrahydrocannabinol. J Neurochem (2005) 0.86

Lack of depolarization-induced suppression of inhibition (DSI) in layer 2/3 interneurons that receive cannabinoid-sensitive inhibitory inputs. J Neurophysiol (2007) 0.82

Articles by these authors

Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A (2010) 1.78

Kalirin-7 is required for synaptic structure and function. J Neurosci (2008) 1.54

Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol (2004) 1.19

Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb Cortex (2006) 1.19

Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol (2004) 1.13

Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. J Neurophysiol (2003) 1.12

Kalirin binds the NR2B subunit of the NMDA receptor, altering its synaptic localization and function. J Neurosci (2011) 1.01

Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission. J Neurophysiol (2008) 1.01

Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. J Neurophysiol (2002) 0.98

Kalirin-7 is necessary for normal NMDA receptor-dependent synaptic plasticity. BMC Neurosci (2011) 0.89

BDNF enhancement of postsynaptic NMDA receptors is blocked by ethanol. Synapse (2005) 0.89

Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro. Alcohol Clin Exp Res (2012) 0.89

Lack of depolarization-induced suppression of inhibition (DSI) in layer 2/3 interneurons that receive cannabinoid-sensitive inhibitory inputs. J Neurophysiol (2007) 0.82

BDNF-endocannabinoid interactions at neocortical inhibitory synapses require phospholipase C signaling. J Neurophysiol (2013) 0.79

Cannabinoid modulation of backpropagating action potential-induced calcium transients in layer 2/3 pyramidal neurons. Cereb Cortex (2012) 0.76

Epileptiform activity in the CA1 region of the hippocampus becomes refractory to attenuation by cannabinoids in part because of endogenous γ-aminobutyric acid type B receptor activity. J Neurosci Res (2012) 0.75